As of now, Australia reports a research & development by business enterprise, pharmaceutical industry in constant ppp $ of 355.06 million, signifying an increase of 37.65 million (11.9%) from 2012.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Australia
No matching regions
Similar regions to Australia
More indicators for Australia
Government R&D in security as % of government support
5.76%
+0.86%
(2021)
Higher-education-finacing R&D financed by general university in local currency
67,353.00M
-873.00M
(2020)
R&D financed by rest of the world in local currency
4,556.00M
-622.00M
(2008)
Government R&D financed by rest of the world in local currency
976.00M
+15.00M
(2020)
Business R&D financed by rest of the world in local currency
4,056.00M
+545.00M
(2021)
Non-profit R&D growth rate
-3.22%
-5.01%
(2021)
Australia Business R&D pharmaceutical in constant PPP $ between 1987 and 2013
| Period | Value | Change |
|---|---|---|
| 2013 | 355.06M | +37.65M |
| 2012 | 317.41M | +43.55M |
| 2011 | 273.86M | +12.39M |
| 2010 | 261.48M | -19.96M |
| 2009 | 281.43M | -22.75M |
| 2008 | 304.18M | +55.71M |
| 2007 | 248.48M | +14.21M |
| 2006 | 234.27M | +23.03M |
| 2005 | 211.25M | -0.31M |
| 2004 | 211.56M | +1.69M |
| 2003 | 209.86M | +20.66M |
| 2002 | 189.20M | -12.00M |
| 2001 | 201.20M | +1.53M |
| 2000 | 199.67M | +11.22M |
| 1999 | 188.45M | +16.33M |
| 1998 | 172.12M | +29.16M |
| 1997 | 142.96M | +5.97M |
| 1996 | 136.99M | -5.30M |
| 1995 | 142.29M | -16.49M |
| 1994 | 158.78M | +23.32M |
| 1993 | 135.46M | +16.07M |
| 1992 | 119.39M | +3.17M |
| 1991 | 116.23M | -1.91M |
| 1990 | 118.14M | +10.28M |
| 1989 | 107.86M | +4.20M |
| 1988 | 103.66M | +23.93M |
| 1987 | 79.74M |